NWRD08 DNA Plasmid for HPV-16 and/or HPV-18 Related Cervical HSIL

Clinical trial NCT06276101 · COMPLETED

Trial details

NCT number: NCT06276101
Sponsor: Newish Technology (Beijing) Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

High-grade Squamous Intraepithelial Lesion (HSIL)

Start date: 2024-05-07
Primary completion: 2025-02-19
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.